BWS
BIIB icon

Buck Wealth Strategies’s Biogen BIIB Stock Holding History

Buck Wealth Strategies’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.16K Buy
+10
New +$1.91K ﹤0.01% 852

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Buck Wealth Strategies's BIIB Position: Q2 2026 in Review

Buck Wealth Strategies opened a new position in Biogen (BIIB) in Q2 2026: 10 shares worth $2.16K. The stake represents ﹤0.01% of the portfolio and ranks #852 among its holdings.

621 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Buck Wealth Strategies held 10 shares of Biogen worth $2.16K as of Q2 2026.
  • Biogen was a new Buck Wealth Strategies position in Q2 2026.
  • Biogen made up ﹤0.01% of Buck Wealth Strategies's portfolio in Q2 2026, its #852 holding.
  • 621 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Buck Wealth Strategies's 13F filing for Q2 2026, filed 30 Jul 2026.